Skip to main content
SpringerLink
Log in

Diagnostic and therapeutic value of airway challenges in asthma

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Airway challenges are of value in the assessment of asthma. Direct challenges (histamine and methacholine) are highly sensitive for clinically current symptomatic asthma and particularly useful to exclude current asthma when they are negative. Indirect challenges (exercise, eucapnic voluntary hyperventilation, adenosine monophosphate, hypertonic saline, mannitol) are more specific but very insensitive for clinical asthma. They are of particular value to confirm asthma and to differentiate asthma from other airway diseases, such as chronic airflow limitation. The indirect stimuli are the challenges of choice for evaluating exercise-induced bronchoconstriction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Tiffeneau R, Beauvallet M: Epreuve de bronchoconstriction et de bronchodilation par aerosols. Bull Acad de Med 1945, 129:165–168.

    Google Scholar 

  2. Pauwels R, Joos G, Van der Straeten M: Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 1988, 18:317–321.

    Article  PubMed  CAS  Google Scholar 

  3. Cockcroft DW, Berscheid BA, Murdock KY: Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest 1983, 83:751–754.

    Article  PubMed  CAS  Google Scholar 

  4. Crapo RO, Casaburi R, Coates AL, et al.: Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000, 161:309–329.

    PubMed  CAS  Google Scholar 

  5. Chai H, Farr RS, Froehlich LA, et al.: Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975, 56:323–327.

    Article  PubMed  CAS  Google Scholar 

  6. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE: Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977, 7:235–243.

    Article  PubMed  CAS  Google Scholar 

  7. deVries K, Goei JT, Booy-Noord H, Orie NGM: Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy 1962, 20:93–101.

    CAS  Google Scholar 

  8. Cockcroft DW, Davis BE, Todd DC, Smycniuk AJ: Methacholine challenge: comparison of two methods. Chest 2005, 127:839–844.

    Article  PubMed  CAS  Google Scholar 

  9. Prieto L, Ferrer A, Domenech J, Pérez-Francés C: Effect of challenge method on sensitivity, reactivity, and maximal response to methacholine. Ann Allergy Asthma Immunol 2006, 97:175–181.

    Article  PubMed  CAS  Google Scholar 

  10. Cockcroft DW, Davis BE: The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test results. J Allergy Clin Immunol 2006, 17:1244–1248.

    Article  CAS  Google Scholar 

  11. Hopp RJ, Bewtra AK, Nair NM, Townley RJ: Specificity and sensitivity of methacholine inhalation challenge in normal and asthmatic children. J Allergy Clin Immunol 1984, 74:154–158.

    Article  PubMed  CAS  Google Scholar 

  12. Cockcroft DW, Berscheid BA, Murdock KY, Gore BP: Sensitivity and specificity of histamine PC20 measurements in a random selection of young college students. J Allergy Clin Immunol 1992, 89:23–30.

    Article  PubMed  CAS  Google Scholar 

  13. Adelroth E, Hargreave FE, Ramsdale EH: Do physicians need objective measurements to diagnose asthma? Am Rev Respir Dis 1986, 134:704–707.

    PubMed  CAS  Google Scholar 

  14. Todd DC, Davis BE, Hurst TS, Cockcroft DW: Dosimeter methacholine challenge: comparison of maximal versus submaximal inhalations. J Allergy Clin Immunol 2004, 114:517–519.

    Article  PubMed  CAS  Google Scholar 

  15. Cockcroft DW, Hargreave FE: Airway hyperresponsiveness: relevance of random population data to clinical usefulness. Am Rev Respir Dis 1990, 142:497–500.

    PubMed  CAS  Google Scholar 

  16. Pattemore PK, Asher MI, Harrison AC, et al.: The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. Am Rev Respir Dis 1990, 142:549–554.

    PubMed  CAS  Google Scholar 

  17. Holzer K, Anderson SD, Chan HK, Douglass J: Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003, 167:534–537.

    Article  PubMed  Google Scholar 

  18. Ramsdale EH, Roberts RS, Morris MM, Hargreave FE: Differences in responsiveness to hyperventilation and methacholine in asthma and chronic bronchitis. Thorax 1985, 40:422–426.

    Article  PubMed  CAS  Google Scholar 

  19. Verma VK, Cockcroft DW, Dosman JA: Airway hyper-responsiveness to inhaled histamine in chronic obstructive airways disease: chronic bronchitis vs. emphysema. Chest 1988, 94:456–461.

    Article  Google Scholar 

  20. Gibson PG, Dolovich J, Denburg J, et al.: Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989, 1:1346–1348.

    Article  PubMed  CAS  Google Scholar 

  21. Irwin RS, French CT, Smyrnios NA, Curley FJ: Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treatment cough-variant asthma. Arch Intern Med 1997, 157:1981–1987.

    Article  PubMed  CAS  Google Scholar 

  22. Cartier A, Pineau L, Malo J-L: Monitoring of maximum expiratory peak flow rates and histamine inhalation tests in the investigation of occupational asthma. Clin Allergy 1984, 14:193–196.

    Article  PubMed  CAS  Google Scholar 

  23. Anderson SD, Argyros GJ, Magnussen H, Holzer K: Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med 2001, 35:344–347.

    Article  PubMed  CAS  Google Scholar 

  24. O’Byrne PM, Ryan G, Morris M, et al.: Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis 1982, 125:281–285.

    PubMed  Google Scholar 

  25. Smith CM, Anderson SD: Inhalational challenges using hypertonic saline in asthmatic subjects: a comparison with responses to hyperpnoea, methacholine and water. Eur Respir J 1990, 3:144–151.

    PubMed  CAS  Google Scholar 

  26. Polosa R, Holgate ST: Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax 1997, 52:919–923.

    Article  PubMed  CAS  Google Scholar 

  27. Poloso R, Ng WH, Crimi N, et al.: Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995, 151:624–629.

    Google Scholar 

  28. Anderson SD, Brannan J, Spring J, et al.: A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997, 156:758–765.

    PubMed  CAS  Google Scholar 

  29. Brannan JD, Koskela H, Anderson SD, Chew N: Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med 1998, 158:1120–1126.

    PubMed  CAS  Google Scholar 

  30. Brannan JD, Gulliksson M, Anderson SD, et al.: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003, 22:491–496.

    Article  PubMed  CAS  Google Scholar 

  31. Brannan JD, Gulliksson M, Anderson SD, et al.: Inhibition of mast cell PGD2 release protects against mannitolinduced airway narrowing. Eur Respir J 2006, 27:944–950.

    PubMed  CAS  Google Scholar 

  32. Pizzichini E, Pizzichini MM, Efthimiadis A: Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996, 154:308–317.

    PubMed  CAS  Google Scholar 

  33. Avital A, Springer C, Bar-Yishay E, Godfrey S: Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995, 50:511–516.

    Article  PubMed  CAS  Google Scholar 

  34. Woolcock AJ, Cheung W, Salome C: Relationship between bronchial responsiveness to propranolol and histamine. Am Rev Respir Dis 1986, 133:A177.

    Google Scholar 

  35. van den Berge M, Meijer RJ, Kerstjens HA, et al.: PC20 adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med 2001, 163:1546–1550.

    Google Scholar 

  36. Choi SH, Kim DK, Yu J, et al.: Bronchial responsiveness to methacholine and adenosine 5′-monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein. Allergy 2007, 62:1119–1124.

    Article  PubMed  CAS  Google Scholar 

  37. Porsbjerg C, Brannan JD, Anderson SD, Backer V: Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy 2008, 38:43–50.

    PubMed  CAS  Google Scholar 

  38. Porsbjerg C, Rasmussen L, Thomsen SF, et al.: Responses to mannitol in asymptomatic subjects with airway hyperresponsiveness to methacholine. Clin Exp Allergy 2007, 37:22–28.

    Article  PubMed  CAS  Google Scholar 

  39. Kim DK, Choi SH, Yu J, et al.: Bronchial responsiveness to methacholine and adenosine 5′-monophosphate in atopic and non-atopic preschool children with recurrent wheezing. Clin Exp Allergy 2007, 37:15–21.

    Article  PubMed  CAS  Google Scholar 

  40. van Velzen E, van den Bos JW, Benckhuijsen JA, et al.: Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996, 51:582–584.

    Article  PubMed  Google Scholar 

  41. van den Berge M, Kerstjens HA, Meijer RJ, et al.: Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 2001, 164:1127–1132.

    PubMed  Google Scholar 

  42. Prosperini G, Rajakulasingam K, Cacciola RR, et al.: Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. J Allergy Clin Immunol 2002, 110:855–861.

    Article  PubMed  CAS  Google Scholar 

  43. Leupi JD, Tandjung R, Anderson SD, et al.: Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulm Pharmacol Ther 2005, 18:83–88.

    Article  CAS  Google Scholar 

  44. Juniper EF, Frith PA, Hargreave FE: Airways responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981, 36:575–579.

    Article  PubMed  CAS  Google Scholar 

  45. Murray AB, Ferguson AC, Morrison B: Airway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1981, 68:119–124.

    Article  PubMed  CAS  Google Scholar 

  46. Green RH, Brightling CE, McKenna S, et al.: Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002, 360:1715–1721.

    Article  PubMed  Google Scholar 

  47. Smith AD, Cowan JO, Brassett KP, et al.: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163–2173.

    Article  PubMed  CAS  Google Scholar 

  48. Sont JK, Willems LN, Bel EH, et al.: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999, 159:1043–1051.

    PubMed  CAS  Google Scholar 

  49. Brannan JD, Koskela H, Anderson SD, Chan HK: Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002, 7:37–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. FRCPC Division of Respirology, Critical Care, and Sleep Medicine, Royal University Hospital, 103 Hospital Drive, Ellis Hall, 5th Floor, Saskatoon, Saskatchewan, S7N 0W8, Canada

    Donald W. Cockcroft

Authors
  1. Donald W. Cockcroft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beth E. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald W. Cockcroft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cockcroft, D.W., Davis, B.E. Diagnostic and therapeutic value of airway challenges in asthma. Curr Allergy Asthma Rep 9, 247–253 (2009). https://doi.org/10.1007/s11882-009-0036-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-009-0036-z

Keywords

Search

Navigation